News Medical on MSN20h
New drug approach shows promise in treating metabolic liver diseasesA MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Medical Xpress on MSN14h
Promising therapeutic approach for metabolic liver diseasesA MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Hosted on MSN5h
New diabetes drug HPH-15 proves to be significantly better than existing wonder drugsDiabetes, a chronic condition impacting millions globally, often brings along complications like insulin resistance and fatty ...
U.S. drugmaker Merck on Wednesday signed a deal worth up to $2 billion with Hansoh Pharmaceuticals to develop and ...
Liver cirrhosis is a serious condition where healthy liver tissue is replaced with scar tissue, making it harder for the ...
Merck & Co. has secured a licensing agreement with Chinese drugmaker Hansoh Pharma for an experimental oral weight-loss drug, ...
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in ...
Seen as a real game-changer in marketing/advertising by most analyst following AI, AppLovin makes technologies that help businesses of every size connect to their ideal customers. The company provides ...
Seen as a real game-changer in marketing/advertising by most analyst following AI, AppLovin (NASDAQ: APP) makes technologies that help businesses of every size connect to their ideal customers. The ...
No trip to Guangzhou is complete without a meal at one of the city’s most iconic restaurants: the aptly named, Guangzhou Restaurant (广州酒家).
The second common sign of high cholesterol in your eyes is corneal arcus. This is a pale, white ring around your iris, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback